책 이미지
책 정보
· 분류 : 외국도서 > 의학 > 종양학
· ISBN : 9783030086275
· 쪽수 : 357쪽
· 출판일 : 2019-02-08
목차
Chapter 1. “Introduction: Motivations for Next-Generation ADCs” -Marc Damelin
Chapter 2. “Combining ADCs with Immuno-oncology Agents” -- Philipp Muller, Jonathan Rios-Doria, Jay Harper and Anthony Cao
Chapter 3. “Improving the Safety Profile of ADCs” -- MagaliGuffroy, HadiFalahatpisheh and Martin Finkelstein
Chapter 4. “Utility of PK-PD Modeling and Simulation to Improve Decision Making for Antibody-Drug Conjugate Development” -- Aman P. Singh and Dhaval K. ShahChapter 5.“Regulatory Considerations and Companion Diagnostics” ? Elizabeth VanAlphen and Omar Perez
Chapter 6. “ADC Process Development and Manufacturing” ? Olivier Marcq
Chapter 7. “HER2-Targeted ADCs: At the forefront of ADC technology development” ? Kevin J. Hamblett
Chapter 8. “Next generation payloads for ADCs” ? L. Nathan TumeyChapter 9.“Delivering more payload: High DAR ADCs” - Natalya Bodyak and Alexander V.Yurkovetskiy
Chapter 10.“Site-Specific Antibody Drug Conjugates” ? Feng Tian, Dowdy Jackson and Yun Bai
Chapter 11. “Bispecific and Biparatopic Antibody-Drug Conjugates” -- Frank Comer, Changshou Gao and Steve Coats
Chapter 12. “Targeting drug conjugates to the tumor microenvironment: Probody Drug Conjugates” -- Jack Lin and Jason Sagert
Chapter 13.“Antibody-Drug Conjugates: Targeting the Tumor Microenvironment” ? Alberto Dal Corso, SamueleCazzamalli and Dario Neri
Chapter 14. “Next Horizons: ADCs Beyond Oncology” -- Shan Yu, Andrew Lim and Matthew S. Tremblay














